Epigenetic PowerBlade - DNA Precision Marks for Critical Illness

表观遗传学 PowerBlade - 危重疾病的 DNA 精密标记

• 批准号: 415719
• 负责人: Dos Santos Claudia C
• 金额: $ 28.58万
• 依托单位: Unity Health Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-10-01 至 2022-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=415719&lang=en
• 关键词: Biomedical Technology; Critical Illness; Dna Methylation; Microfluidic; Point Of Care Device; Prognosis; Sepsis; Therapeutic Enrichment; Whole Blood

Sepsis, whole body inflammation and organ failure triggered by an overwhelming and unbalanced response to infection, incurs enormous human and health care costs. Globally, over 30 million people are affected each year, at least a quarter of whom will die.

由对感染的压倒性和不平衡的反应引发的脓毒症、全身炎症和器官衰竭导致巨大的人力和卫生保健成本。在全球范围内，每年有3 000多万人受到影响，其中至少四分之一的人将死亡。